Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by RedHill Biopharma Ltd

RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib
From RedHill Biopharma Ltd
Via AccessWire
Tickers RDHL
RedHill Announces Additional Insider Buying
From RedHill Biopharma Ltd
Via AccessWire
Exposures COVID-19
Tickers RDHL
RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Ltd - Opaganib MoA Not Impacted by Omicron Mutations
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Ltd Announces Talicia: Consistent Efficacy Irrespective of BMI
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill’s Movantik Added To Medicare Formulary
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Reports 3Q/2021 Financial Results
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Ltd Announces RedHill: LPI in Part A of RHB-107 P2/3 COVID Study
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Presents New Talicia(R) and Movantik(R) Data Analyses at ACG 2021
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Announces Insider Buying
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Ltd Announces New U.S. Patent for RedHill's Talicia for H.pylori
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Ltd Announces Talicia(R) added to Medi-Cal CDL
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients
From RedHill Biopharma Ltd
Via AccessWire
Topics Death Intellectual Property Regulatory Compliance
Exposures COVID-19 Death Intellectual Property
Tickers RDHL
RHB-107 P2/3 COVID-19 Study South Africa Approval
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Ltd Announces New Movantik Analyses at PAINWeek
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill to Present at HCW & Cantor Conferences
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Reports Second Quarter 2021 Results
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance Supply Chain
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Ltd Announces RedHill's Opaganib Strong Delta Variant Inhibition
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Announces Two New U.S. Patents
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Settles Movantik(R) Apotex Patent Litigation
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
RedHill Extends Talicia Commercial Coverage
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
RedHill Biopharma Ltd Announces RedHill Biopharma Announces Last Patient Out
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers RDHL
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.